Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Childhood Myelodysplastic Syndromes|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Disseminated Neuroblastoma|Malignant Neoplasm|Ovarian Choriocarcinoma|Ovarian Embryonal Carcinoma|Ovarian Immature Teratoma|Ovarian Mature Teratoma|Ovarian Mixed Germ Cell Tumor|Ovarian Monodermal and Highly Specialized Teratoma|Ovarian Polyembryoma|Ovarian Yolk Sac Tumor|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Malignant Testicular Germ Cell Tumor|Recurrent Mantle Cell Lymphoma|Recurrent Neuroblastoma|Recurrent Ovarian Epithelial Cancer|Recurrent Ovarian Germ Cell Tumor|Refractory Chronic Lymphocytic Leukemia|Refractory Multiple Myeloma|Relapsing Chronic Myelogenous Leukemia|Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage II Ovarian Epithelial Cancer|Stage III Malignant Testicular Germ Cell Tumor|Stage III Multiple Myeloma|Stage III Ovarian Epithelial Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer|Stage IV Ovarian Epithelial Cancer|Testicular Choriocarcinoma|Testicular Choriocarcinoma and Embryonal Carcinoma|Testicular Choriocarcinoma and Seminoma|Testicular Choriocarcinoma and Teratoma|Testicular Choriocarcinoma and Yolk Sac Tumor|Testicular Embryonal Carcinoma|Testicular Embryonal Carcinoma and Seminoma|Testicular Embryonal Carcinoma and Teratoma|Testicular Embryonal Carcinoma and Teratoma With Seminoma|Testicular Embryonal Carcinoma and Yolk Sac Tumor|Testicular Embryonal Carcinoma and Yolk Sac Tumor With Seminoma|Testicular Teratoma|Testicular Yolk Sac Tumor|Testicular Yolk Sac Tumor and Teratoma|Testicular Yolk Sac Tumor and Teratoma With Seminoma
Interventions: DRUG: ipilimumab|DRUG: therapeutic allogeneic lymphocytes
Sponsor: National Cancer Institute (NCI)